Benzodiazepine receptor binding: the interactions of some non-benzodiazepine drugs with specific [3H] diazepam binding to rat brain synaptosomal membranes
- PMID: 723967
- DOI: 10.1007/BF00497002
Benzodiazepine receptor binding: the interactions of some non-benzodiazepine drugs with specific [3H] diazepam binding to rat brain synaptosomal membranes
Abstract
The interaction of several non-benzodiazepine drugs with [3H] diazepam binding to benzodiazepine receptors in rat brain synaptosomal membranes was investigated. Baclofen, benzoctamine, hydroxyzine, chlorpromazine, haloperidol, imipramine, and amitriptyline displace specific [3H] diazepam binding, but the concentrations needed are too high to explain pharmacological effects of these drugs by an interaction with benzodiazepine receptors. The most potent non-benzodiazepine drug for inhibiting specific [3H] diazepam binding was methaqualone (IC50 value of 150 micrometer). It is suggested that interactions with benzodiazepine receptors may account for the anxiolytic and anticonvulsive side effects of this drug. The analeptic drug pentylenetetrazole interacts with benzodiazepine receptor binding with an IC50 value of about 1 mM, which is possibly too high to explain its convulsive properties by an antagonism at the benzodiazepine receptor.
Similar articles
-
Inosine, an endogenous ligand of the brain benzodiazepine receptor, antagonizes pentylenetetrazole-evoked seizures.Proc Natl Acad Sci U S A. 1979 Mar;76(3):1515-8. doi: 10.1073/pnas.76.3.1515. Proc Natl Acad Sci U S A. 1979. PMID: 286337 Free PMC article.
-
Brain-specific benzodiazepine receptors and putative endogenous benzodiazepine-like compounds.Biol Psychiatry. 1980 Jun;15(3):407-28. Biol Psychiatry. 1980. PMID: 6103718
-
Pharmacological characterization of benzodiazepine receptors in the brain.Eur J Pharmacol. 1978 Apr 1;48(3):263-70. doi: 10.1016/0014-2999(78)90085-7. Eur J Pharmacol. 1978. PMID: 639854
-
CNS benzodiazepine receptors: physiological studies and putative endogenous ligands.Pharmacol Biochem Behav. 1979 May;10(5):815-23. doi: 10.1016/0091-3057(79)90340-x. Pharmacol Biochem Behav. 1979. PMID: 40256 Review.
-
Electron-transfer and charge-transfer clastic binding hypotheses for drug-receptor interactions.Pharm Res. 1987 Dec;4(6):450-6. doi: 10.1023/a:1016415202819. Pharm Res. 1987. PMID: 3334168 Review.
Cited by
-
1-Methyl-beta-carboline (harmane), a potent endogenous inhibitor of benzodiazepine receptor binding.Naunyn Schmiedebergs Arch Pharmacol. 1980 Oct;314(1):97-100. doi: 10.1007/BF00498436. Naunyn Schmiedebergs Arch Pharmacol. 1980. PMID: 6255348
-
Interactions of some anaesthetic, convulsant, and anticonvulsant drugs at GABA-benzodiazepine receptor-ionophore complexes in rat brain synaptosomal membranes.Neurochem Res. 1983 Oct;8(10):1351-62. doi: 10.1007/BF00964003. Neurochem Res. 1983. PMID: 6318143
-
A Multifaceted GABAA Receptor Modulator: Functional Properties and Mechanism of Action of the Sedative-Hypnotic and Recreational Drug Methaqualone (Quaalude).Mol Pharmacol. 2015 Aug;88(2):401-20. doi: 10.1124/mol.115.099291. Epub 2015 Jun 8. Mol Pharmacol. 2015. PMID: 26056160 Free PMC article.
-
Beta-carboline binding indicates the presence of benzodiazepine receptor subclasses in the bovine central nervous system.Naunyn Schmiedebergs Arch Pharmacol. 1982 May;319(2):172-7. doi: 10.1007/BF00503933. Naunyn Schmiedebergs Arch Pharmacol. 1982. PMID: 6287307
-
The effects of chlormethiazole on single unit activity in rat brain; interactions with inhibitory and excitatory neurotransmitters.Br J Pharmacol. 1983 Nov;80(3):439-44. doi: 10.1111/j.1476-5381.1983.tb10713.x. Br J Pharmacol. 1983. PMID: 6139135 Free PMC article.